You can buy or sell OncoSec and other stocks, options, ETFs, and crypto commission-free!
OncoSec Medical Incorporated Common Stock, also called OncoSec, is a biotechnology company, which engages in designing, developing, and commercializing therapies for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. Read More The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered inPennington, NJ.
Pennington, New Jersey
52 Week High
52 Week Low
Expected Dec 13, After Hours